Joshua DeTillio - 01 Mar 2025 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role: Chief Operating Officer
Signature: /s/ Joshua DeTillio
Issuer symbol: NUTX
Transactions as of: 01 Mar 2025
Net transactions value: -$32,588
Form type: 4
Filing time: 14 Apr 2025, 16:01:59 UTC
Previous filing: 21 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUTX	Common Stock	Options Exercise	$0	+2,125	+44%	$0.000000	6,933	01 Mar 2025	Direct	F1
transaction	NUTX	Common Stock	Tax liability	$32,588	-452	-6.5%	$72.10	6,481	04 Apr 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUTX	Restricted Stock Units	Options Exercise	$0	+5,950	+140%	$0.000000	10,200	01 Mar 2025	Common Stock	5,950	$0.000000	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Of the 2,125 shares issued subsequent to vesting, 452 shares were sold to cover tax withholding obligations.
F3	On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.